Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DiSCERN: Advanced PD Therapy Candidacy and Evaluation System - Advanced PD Data Collection

NCT05351580 is registered in ClinicalTrials.gov with Great Lakes NeuroTechnologies Inc. as lead sponsor.

NCT NCT05351580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05351580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DiSCERN: Advanced PD Therapy Candidacy and Evaluation System - Advanced PD Data Collection
Lead sponsor
Great Lakes NeuroTechnologies Inc.
Phase
Observational
Overall status
Completed
Start date
July 21, 2022
Completion date
June 30, 2024
Enrollment
26 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease